Connor Hussey

Large asset managers’ participation in venture capital deals is nothing new. But it has only grown in recent years, and non-traditional investors are now going downstream even more, participating in outsized seed deals. The competition that has emerged will likely impact VC for years to come.

'Most companies are, in some ways, becoming a fintech company,' says Addie Lerner of Avid Ventures, as the fintech industry grows to record heights this year. The future of the industry might exist beyond US borders.

Following 2020’s record year, more and more capital is pouring into venture as 2021 is poised to set new records. But investments don’t seem to be performing as they once did.

The covid-19 pandemic that shut down markets in early 2020 is now helping to lift healthcare investing, which has surged in the first half of 2021, according to a new report by Silicon Valley Bank.

Data suggests emerging managers have struggled during the pandemic, but stats ignore the increasing importance they have to the industry.

Venture capital is in the midst of another record year marked by record dealmaking at early and late stages, the introduction of huge swaths of capital from non-VC investors and record numbers of mega-deals driving valuations to new heights.

Following the US SPAC boom of 2020 and Q1 2021, many US-based SPACs are snatching up European targets for high valuations.

As StepStone looks to expand its VC offering by acquiring Greenspring, the combined firm will make investment decisions by way of a joint investment committee.

Food technology proved vital during the pandemic but fundraising and deal activity in this space continues to rage on in what will surely be a record year.

Venture Capital Journal caught up with M12's managing director Matthew Goldstein to discuss the landscape for investing in Europe and why the conditions are ripe for growth in seed-stage investing.